CV Sciences (CV Sciences) Growth Rank : 0 (As of Apr. 29, 2024)

View and export this data going back to 2011. Start your Free Trial

What is CV Sciences Growth Rank?

CV Sciences has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

CV Sciences Growth Rank Related Terms

Thank you for viewing the detailed overview of CV Sciences's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

CV Sciences (CV Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CV Sciences Inc (OTCPK:CVSI) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

9530 Padgett Street, Suite 107, San Diego, CA, USA, 92126

Website

https://www.cvsciences.com

CV Sciences Inc is a consumer wellness company specializing in hemp extracts and other proven, science-backed, natural ingredients and products, which are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). The company also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based novel therapeutics.

Executives

William Mccorkle	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Corroon James Michael Jr.	director	9530 PADGETT STREET, SUITE 107, SAN DIEGO CA 92126
Maroon Joseph C Md	director	2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Mona Michael Joseph Jr	director	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Paul Blake	director	145 BRANDYWINE PKWY, WEST CHESTER PA 19380
Douglas Jesse Mackay	officer: Sr VP Scientific/Regulatory	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Joseph D Dowling	officer: Chief Financial Officer	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Joerg Grasser	officer: CFO	2688 SOUTH RAINBOW BLVD STE B, LAS VEGAS NV 89146
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Terri F Graham	director	C/O JACK IN THE BOX INC, 9330 BALVOA AVE, SAN DIEGO CA 92123
Stephen Martin Schmitz	director	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Gary Sligar	director	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
James A Mcnulty	director	C/O CV SCIENCES, INC., 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Larry Phillip Raskin	director	1630 FUNNY CIDE DRIVE, WAXHAW NC 28173
Mackay Ventures Inc.	other: Member 10% holding group	6325 S. JONES BOULEVARD #500, LAS VEGAS NV 89118